Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on May 20, 2024 1:21pm
64 Views
Post# 36048829

RE:RE:clueless

RE:RE:cluelessHey wazzak...

I see crypto is doing great again today... how is ONCY looking after the AGM and fireside chat... are we in any danger of seeing some stock price appreciation yet..? As you pumpers think this is going to the moon, I just wonder in what you think this might happen..?

On 15th May, Crispr had a fireside chat too... you should listen to that... interesting to compare the two companies.

ONCY - 26 years old... since 1998, share price destruction of 99%, 20 million in cash, 1 failed phase III, 8 years of promising another Phase III, no partnerships to buy the company or pay for the pending trials, which won't start until 2025 now... Investors might start feeling concerned that with these timelines, the main patent for Pela will expire before they get approval, and some other Jonny come lately will steal the prize... my precioussssssss

CRSP - 10 years old, 2 BILLION in cash, 1 product recently approved in multiple markets for 2 indications, huge potential in Middle East (SA), amongst other markets. an enviable portfolio of cancer (including solid cancers) and immunotherapy treatments / trials underway... CRSPrs cash runaway will see them reach multiple inflection points over the next few years with no further need for dilution...

Jeez, amazing what a well run company can do in 10 years...  The Phase II IND-213 trial started 12 years ago... TWELVE... in the time it has taken ONCY to dither about what to do next, CRSP has taken an entirely novel class of therapeutic through to approval for a hitherto incurable condition.

High School..?? "It takes a smart mind to resist an education.. " LOL... 

<< Previous
Bullboard Posts
Next >>